CT
Cantabio Pharmaceuticals, Inc.
CTBO · OTC
$1.01 +0.00% (+$0.00)
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Valuation
-
N/A P/B N/A
P/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 456.60x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CTBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gergely Tóth
Employees
451
Headquarters
Palo Alto